Press Release

API Holdings Turns Debt-Free — Repays Rs 1,050 Crore, Frees Thyrocare Shares from Pledge

Term loan cleared via Thyrocare stake sale and internal accruals; Docon retains 51.02% controlling stake, now fully unencumbered

Simran

Aug 21, 2026 - 17:12

Press Release

Read more on hindustanmetro.com

21 Aug 2026

API Holdings Turns Debt-Free — Repays Rs 1,050 Crore, Frees Thyrocare Shares from Pledge

Mumbai (Maharashtra) [India], August 17: API Holdings, India's largest digital healthcare platform and the ultimate parent company of Thyrocare, has become debt-free after repaying its outstanding debt of ₹1,050 crore, funded through proceeds from the recent sale of a portion of its stake in Thyrocare Technologies and internal accruals.

The development comes after Docon Technologies Private Limited, the promoter and holding company of Thyrocare, sold 1,57,69,696 Thyrocare shares, representing around 9.90% of the company’s paid-up equity share capital, through market trades. Following the sale, Docon continues to remain the promoter and holding company of Thyrocare with a 51.02% stake.

The debt payment has also resulted in the release of the pledge on the remaining Thyrocare shares held by Docon. The entire outstanding pledge linked to the debt has now been released, leaving Docon’s 51.02% holding in Thyrocare fully unencumbered.

Alok Kumar Jagnani, Whole-Time Director and Group CFO, API Holdings, said, “We’ve repaid our term debt in full, and we did it the hard way, without diluting our stake in Thyrocare below 51%. That’s the real headline: a stronger balance sheet without giving up our ownership. It reflects a capital allocation philosophy where growth and discipline aren’t traded off against each other. With every business in the group soon profitable, there’s no drag left on the P&L ; just a clean base to build from.”

Siddharth Shah, Vice Chairman, API Holdings, said, “The Thyrocare acquisition has worked out well for API. Shareholders who held on instead of tendering to our open offer at ₹433 a share in July 2021 (bonus adjusted) are sitting on ₹653 at close of trading on 14th August 2026 - dividends included. That’s a 51% return. NIFTY 50 gave you 41%. Pathology peers weren’t even close. True value for money! Congratulations to the Thyrocare team, a turnaround nobody thought was possible.”

Rahul Guha, MD & CEO, API Holdings and Thyrocare, said, “Zero debt isn’t the finish line; it's the starting gun. This wasn’t financial engineering; it was Thyrocare’s and the group's execution, quarter after quarter, that made it possible. What the team proved is bigger than a balance sheet: this organisation can execute on anything it sets its mind to. That’s the real asset we’re carrying into the next chapter.”

With its term loan fully repaid and businesses moving into profitability, API Holdings now enters its next phase focused on profitable growth, disciplined execution and long-term value creation across its healthcare businesses.

Disclaimer: This is a sponsored press release. The publisher does not in any manner whatsoever endorse/subscribe to the contents of this article and/or views expressed herein. Reader discretion is advised.